ByteDance's drug unit showed an AI-designed IL-17 inhibitor at a Boston conference. The molecule targets interactions pharma called undruggable. Only trials will tell.

Building on a long-standing MIT-IBM collaboration, the new lab will chart the convergence of AI, algorithms, and quantum ...

The following is a joint announcement by the MIT Schwarzman College of Computing and IBM.IBM and MIT today announced the ...

Due to the explosive growth of artificial intelligence, it is estimated that data centers will consume up to 12% of total U.S ...

Chemists and computer scientists tapped AI to find new disinfectants to combat the growing threat of dangerous "superbugs." ...

From executive shakeups to "Agentic Ready" payments, the industry's biggest players are pivoting to meet the next era of ...

For the first time, researchers directly characterized the 3D atomic structure of a relaxor ferroelectric, a class of ...

Amjad Masad said that young people who are not deeply interested in computer science should not study it.

Materials called relaxor ferroelectrics have been used for decades in technologies like ultrasounds, microphones, and sonar ...

Bittensor co-founder Jacob Steeves outlined how $TAO builds decentralized AI infrastructure using incentive design and subnet ...

On his third day of testimony, Elon Musk will be cross-examined by lawyers from OpenAI and Microsoft. His answers on the ...

AI can match doctors in diagnostic reasoning, but experts warn rapid progress outpaces safeguards needed for real-world use.